Cross-Border Merger
A Cross-Border Merger is a business combination involving companies incorporated or domiciled in different countries, requiring compliance with the corporate, securities, tax, antitrust, and foreign investment laws of multiple jurisdictions simultaneously, and typically resulting in a combined entity domiciled in one of the parties' home countries or a third jurisdiction.
Cross-Border Mergers are among the most legally and operationally complex transactions in corporate finance. Unlike domestic mergers, which are governed by the laws of a single jurisdiction, Cross-Border Mergers must satisfy the merger approval and disclosure requirements of every country where either party is incorporated, publicly listed, or has material operations. This multi-jurisdictional character creates challenges in structuring, timing, documentation, and regulatory approvals that do not arise in purely domestic transactions.
The choice of deal structure in a Cross-Border Merger is heavily influenced by the applicable laws of the parties' home jurisdictions. A U.S. company acquiring a European company might structure the transaction as a statutory merger under Delaware law using a reverse triangular merger structure, with the foreign target becoming a subsidiary of a U.S. holding company. Alternatively, the parties might use a scheme of arrangement under English law if the target is UK-incorporated — a court-approved transaction structure that binds all shareholders once approved by the requisite majority, eliminating the holdout problem that can arise in traditional tender offer structures.
Regulatory approvals in Cross-Border Mergers can involve antitrust reviews by the U.S. Department of Justice or Federal Trade Commission, the European Commission's Directorate-General for Competition, the China State Administration for Market Regulation (SAMR), and potentially a dozen or more additional competition authorities depending on the geographic footprint of the parties. Each regulator applies its own substantive standards, procedural requirements, and timelines, and approval in one jurisdiction does not guarantee approval in another.
Foreign investment screening has become an increasingly significant consideration in Cross-Border Mergers. In the United States, the Committee on Foreign Investment in the United States (CFIUS) reviews transactions in which a foreign person acquires a U.S. business for national security implications. CFIUS review timelines, the scope of covered transactions, and the potential for mitigation agreements or transaction prohibition have expanded significantly under the Foreign Investment Risk Review Modernization Act (FIRRMA) of 2018. Comparable regimes have been established or strengthened in the EU, UK, Canada, Australia, Japan, and elsewhere.
The tax structuring of Cross-Border Mergers is complex. The parties must analyze whether the transaction is taxable or tax-free in each relevant jurisdiction, the withholding tax treatment of consideration paid to shareholders, transfer pricing implications for intercompany arrangements in the combined entity, and treaty access for the post-merger corporate structure. These considerations frequently influence the choice of the surviving legal entity's domicile and can result in the use of holding company structures in favorable treaty jurisdictions to optimize the combined group's global effective tax rate.